Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 3

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Evaluating Financial Incentives as a Tool to Increase Medication Adherence for Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

Winberg, Debra, Tang, Tiange, Ramsey, Zachary, Bazzano, Alessandra N., Nauman, Elizabeth, Li, Jian, Lin, Yilu, Shi, Lizheng · 2025 · Diabetes Therapy

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13300-025-01694-y

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 50

  1. Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008;88(11):1322–35. · DOI · Paper page
  2. Lafeuille MH, Grittner AM, Gravel J, Bailey RA, Martin S, Garber L, et al. Quality measure attainment in patients with type 2 diabetes mellitus. Am J Manag Care. 2014;20(1 Suppl):s5-15.
  3. Morris JL, Chasens ER. Financial difficulty: a barrier to self-care in patients with diabetes. Diabetes Educ. 2017;43(3):247–8. · doi:10.1177/0145721717703486
  4. Doshi JA, Li P, Ladage VP, Pettit AR, Taylor EA. Impact of cost sharing on specialty drug utilization and outcomes: a review of the evidence and future directions. Am J Manag Care. 2016;22(3):188–97.
  5. Choe HM, Stevenson JG, Streetman DS, Heisler M, Sandiford CJ, Piette JD. Impact of patient financial incentives on participation and outcomes in a statin pill-splitting program. Am J Manag Care. 2007;13(6 Part 1):298–304.
  6. Jackson T, Shields MD, Heaney LG, Kendall M, Pearce CJ, Hui CY, et al. The impact of financial incentives on the implementation of asthma or diabetes self-management: a systematic review. PLoS ONE. 2017;12(11): e0187478. · DOI
  7. Fusco N, Sils B, Graff JS, Kistler K, Ruiz K. Cost-sharing and adherence, clinical outcomes, health care utilization, and costs: a systematic literature review. J Manag Care Spec Pharm 2022; https://doi.org/10.18553/jmcp.2022.21270 · DOI
  8. Sensharma A, Yabroff KR. Do interventions that address patient cost-sharing improve adherence to prescription drugs? A systematic review of recently published studies. Expert Rev Pharmacoecon Outcomes Res. 2019;19(3):263–77. · DOI
  9. Ihle P, Krueger K, Schubert I, Griese-Mammen N, Parrau N, Laufs U, et al. Comparison of different strategies to measure medication adherence via claims data in patients with chronic heart failure. Clin Pharmacol Ther. 2019;106(1):211–8. · DOI
  10. Weir CJ, Butcher I, Assi V, Lewis SC, Murray GD, Langhorne P, et al. Dealing with missing standard deviation and mean values in meta-analysis of continuous outcomes: a systematic review. BMC Med Res Methodol. 2018;18(1):25. · DOI · Paper page
  11. Reis DJ, Kaizer AM, Kinney AR, et al. A practical guide to random-effects Bayesian meta-analyses with application to the psychological trauma and suicide literature. Psychol Trauma. 2023;15(1):121. · DOI
  12. Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res. 2020;7(1):7.
  13. Hohmann NS, Hastings TJ, Jeminiwa RN, Qian J, Hansen RA, Ngorsuraches S, et al. Patient preferences for medication adherence financial incentive structures: a discrete choice experiment. Res Social Adm Pharm. 2021;17(10):1800–9. · DOI
  14. Bilger M, Shah M, Tan NC, Tan CYL, Bundoc FG, Bairavi J, et al. Process- and outcome-based financial incentives to improve self-management and glycemic control in people with Type 2 diabetes in Singapore: a randomized controlled trial. Patient. 2021;14(5):555–67. · DOI
  15. Chang A, Liberman JN, Coulen C, Berger JE, Brennan TA. Value-based insurance design and antidiabetic medication adherence. Am J Pharm Benefits. 2010;2(1):39–44.
  16. Clark B, DuChane J, Hou J, Rubinstein E, McMurray J, Duncan I. Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications. J Manag Care Pharm. 2014;20(2):141–50.
  17. Gibson TB, Wang S, Kelly E, Brown C, Turner C, Frech-Tamas F, et al. A value-based insurance design program at a large company boosted medication adherence for employees with chronic illnesses. Health Aff (Millwood). 2011;30(1):109–17. · DOI
  18. Gibson TB, Mahoney J, Ranghell K, Cherney BJ, McElwee N. Value-based insurance plus disease management increased medication use and produced savings. Health Aff (Millwood). 2011;30(1):100–8. · DOI
  19. Gibson TB, Mahoney JJ, Lucas K, Heithoff K, Gatwood J. Value-based design and prescription drug utilization patterns among diabetes patients. Am J Pharm Benefits. 2013;5(3):113–20.
  20. Gokhale M, Dusetzina SB, Pate V, Chun DS, Buse JB, Stürmer T, et al. Decreased antihyperglycemic drug use driven by high out-of-pocket costs despite medicare coverage gap closure. Diabetes Care. 2020;43(9):2121–7. · DOI
  21. Kim NH, Look KA. The effect of reduced drug copayments on adherence to oral diabetes medications among childless adults in Wisconsin Medicaid. J Manag Care Spec Pharm. 2019;25(12):1432–41.
  22. Kong E, Beshears J, Laibson D, Madrian B, Volpp K, Loewenstein G, et al. Do physician incentives increase patient medication adherence? Health Serv Res. 2020;55(4):503–11. · DOI
  23. Karter AJ, Parker MM, Solomon MD, Lyles CR, Adams AS, Moffet HH, et al. Effect of out-of-pocket cost on medication initiation, adherence, and persistence among patients with Type 2 diabetes: The Diabetes Study of Northern California (DISTANCE). Health Serv Res. 2018;53(2):1227–47. · DOI
  24. Maciejewski ML, Farley JF, Parker J, Wansink D. Copayment reductions generate greater medication adherence in targeted patients. Health Aff (Millwood). 2010;29(11):2002–8. · DOI
  25. Musich S, Wang S, Hawkins K. The impact of a value-based insurance design plus health coaching on medication adherence and medical spending. Popul Health Manag. 2015;18(3):151–8. · DOI
  26. Peaslee A, Wickizer M, Olson J, Topp R. Impact of a combined value-based insurance design and medication therapy management program on diabetes medication adherence. J Manag Care Spec Pharm. 2016;22(11):1303–9.
  27. Polinski JM, Shrank WH, Huskamp HA, Glynn RJ, Liberman JN, Schneeweiss S. Changes in drug utilization during a gap in insurance coverage: An examination of the medicare part d coverage gap. PLoS Medicine. 2011;8(8): e1001075. · DOI
  28. Pooler JA, Srinivasan M. Association between supplemental nutrition assistance program participation and cost-related medication non-adherence among older adults with diabetes. JAMA Intern Med. 2019;179(1):63–70. · DOI
  29. Rastas C, Bunker D, Gampa V, Gaudet J, Karimi S, Majidi A, et al. Association between high deductible health plans and cost-related non-adherence to medications among americans with diabetes: an observational study. J Gen Intern Med. 2021;37:1910–6. · DOI
  30. Reiss SK, Ross-Degnan D, Zhang F, Soumerai SB, Zaslavsky AM, Wharam JF. Effect of switching to a high-deductible health plan on use of chronic medications. Health Serv Res. 2011;46(5):1382–401. · DOI
  31. Roblin DW, Platt R, Goodman MJ, Hsu J, Nelson WW, Smith DH, et al. Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: How much is too much? Med Care. 2005;43(10):951–9. · DOI
  32. Sullivan SD, Yeung K, Vogeler C, Ramsey SD, Wong E, Murphy CO, et al. Design, implementation, and first-year outcomes of a value-based drug formulary. J Manag Care Spec Pharm. 2015;21(4):269–75.
  33. Wang V, Liu CF, Bryson CL, Sharp ND, Maciejewski ML. Does medication adherence following a copayment increase differ by disease burden? Health Serv Res. 2011;46(6):1963–85. · DOI
  34. Wong ES, Maciejewski ML, Liu CF. Does the association between prescription copayment increases and medication adherence differ by race? J Health Care Poor Underserved. 2013;24(3):1317–30. · DOI
  35. Zeng F, An JJ, Scully R, Barrington C, Patel BV, Nichol MB. The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation. Value Health. 2010;13(6):846–52. · DOI
  36. Latham LP, Marshall EG. Performance-based financial incentives for diabetes care: an effective strategy? Can J Diabetes. 2015;39(1):83–7. · DOI
  37. Hung A, Blalock DV, Miller J, McDermott J, Wessler H, Oakes MM, et al. Impact of financial medication assistance on medication adherence: a systematic review. J Manag Care Spec Pharm. 2021;27(7):924–35.
  38. DeFulio A, Silverman K. The use of incentives to reinforce medication adherence. Prev Med. 2012;55(Suppl):S86-94. · DOI
  39. Jeminiwa R, Hohmann SN, Hastings JT, Hansen R, Qian J, Garza BK. Individuals’ preference for financial over social incentives for medication adherence. J Am Pharm Assoc. 2022;62(1):134-41.e1. · DOI
  40. Noordraven LE, Schermer NHM, Blanken P, Mulder LC, Wierdsma IA. Ethical acceptability of offering financial incentives for taking antipsychotic depot medication: patients’ and clinicians’ perspectives after a 12-month randomized controlled trial. BMC Psychiatry. 2017. https://doi.org/10.1186/s12888-017-1485-x. · DOI
  41. Vlaev I, King D, Darzi A, Dolan P. Changing health behaviors using financial incentives: a review from behavioral economics. BMC Public Health. 2019. https://doi.org/10.1186/s12889-019-7407-8. · DOI · Paper page
  42. Priebe S, Yeeles K, Bremner S, Lauber C, Eldridge S, Ashby D, et al. Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial. BMJ. 2013;347(7oct07 3):f5847. https://doi.org/10.1136/bmj.f5847. · DOI
  43. Nichols GA, Rosales AG, Kimes TM, Tunceli K, Kurtyka K, Mavros P. The change in HbA1c associated with initial adherence and subsequent change in adherence among diabetes patients newly initiating metformin therapy. J Diabetes Res. 2016;2016:9687815. · DOI
  44. Mata-Cases M, Rodríguez-Sánchez B, Mauricio D, Real J, Vlacho B, Franch-Nadal J, et al. The association between poor glycemic control and health care costs in people with diabetes: a population-based Study. Diabetes Care. 2020;43(4):751–8. · DOI
  45. Barankay I, Reese PP, Putt ME, Russell LB, Loewenstein G, Pagnotti D, et al. Effect of patient financial incentives on statin adherence and lipid control: a randomized clinical trial. JAMA Netw Open. 2020;3(10): e2019429. · DOI · Paper page
  46. Nally ML, Wagner J, Sherr J, Tichy E, Weyman K, Ginley KM, et al. A pilot study of youth with Type 1 diabetes initiating use of a hybrid closed-loop system while receiving a behavioral economics intervention. Endocr Pract. 2021;27(6):545–51. · DOI
  47. Gross CA, Freese LR, Bensignor OM, Bomberg ME, Dengel RD, Fox KC, et al. Financial incentives and treatment outcomes in adolescents with severe obesity. JAMA Pediatr. 2024;178(8):753. · DOI
  48. Desai JR, Vazquez-Benitez G, Taylor G, Johnson S, Anderson J, Garrett JE, et al. The effects of financial incentives on diabetes prevention program attendance and weight loss among low-income patients: the we can prevent diabetes cluster-randomized controlled trial. BMC Public Health. 2020;20(1):1587. · DOI
  49. Noordraven EL, Wierdsma AI, Blanken P, Bloemendaal AFT, Mulder CL. Medical and social costs after using financial incentives to improve medication adherence: results of a 1 year randomised controlled trial. BMC Res Notes. 2018;11(1):655. · doi:10.1186/s13104-018-3747-1
  50. Henderson C, Knapp M, Yeeles K, Bremner S, Eldridge S, David AS, et al. Cost-effectiveness of financial incentives to promote adherence to depot antipsychotic medication: economic evaluation of a cluster-randomised controlled trial. PLoS One. 2015;10(10): e0138816. · DOI

Cited by

See all 3

Metadata

Authors
Winberg, D., Tang, T., Ramsey, Z., Bazzano, A. N., Nauman, E., Li, J., Lin, Y., & Shi, L.
Venue
Diabetes Therapy
Published
2025-02-10
ISSN
  • 1869-6953
  • 1869-6961
Cited by
3
References
7
Language
en
Licence
Funders
Centers for Disease Control and Prevention (1U18DP006523-01)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluating Financial Incentives as a Tool to Increase Medication Adherence for Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1007/s13300-025-01694-y
The paper
Winberg, D., Tang, T., Ramsey, Z., Bazzano, A. N., Nauman, E., Li, J., Lin, Y., & Shi, L. (2025). Evaluating Financial Incentives as a Tool to Increase Medication Adherence for Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Diabetes Therapy. https://doi.org/10.1007/s13300-025-01694-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.